Key result
The 2017 ACC/AHA hypertension guideline update reclassifies BP stages and lowers treatment goals.
Why the study?
Hypertension affects about one-third of US adults and contributes significantly to mortality, necessitating updated evidence-based treatment guidelines.
This review highlights key updates in the 2017 ACC/AHA hypertension guidelines, specifically the reclassification of blood pressure stages and the lowering of treatment targets.
Alerts clinicians to reclassified BP stages and lower targets; leaves open outcome validation in diverse populations.
In the United States, hypertension affects about one-third of adults and contributes to one out of every seven deaths. Evidence-based treatment is associated with reductions in incidence of stroke, myocardial infarction, and heart failure as well as associated disability and death. This article reviews the ACC/AHA Task Force on Clinical Practice Guidelines' 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Key changes include reclassification of BP stages and lowering of hypertension treatment goals.
No takes yet. Share an insight, caveat, or question.
DePalma et al. (2018) conducted a review in Hypertension. 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults was evaluated. The 2017 ACC/AHA hypertension guideline update introduces key changes including the reclassification of blood pressure stages and the lowering of hypertension treatment goals.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: